Intec Pharma Ltd
NTEC
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$23.53
144.4% upside
Current Fair Value
144.4% upsideUndervalued by 144.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-10,135,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.3 |
| Beta | 1.14 |
| Outstanding Shares | 1,104,750 |
Return
| Return on Equity | -127.71% |
|---|---|
| Return on Assets | -83.12% |
| Return on Invested Capital | -117.55% |
Valuation & Multiples
| P/E Ratio | -0.67 |
|---|---|
| PEG | -7.26 |
| Price to Sales | - |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.71 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Intec Pharma Ltd
CEO: Jeffrey Meckler